paramesonephric duct

**Embryology** - Paramesonephric ducts arise from invagination of coelomic (mesothelial) epithelium lateral to the mesonephric (Wolffian) ducts around week 6. They are present in both sexes initially (indifferent stage). - **Female (default pathway):** No SRY → no testis → no AMH. Ducts persist and the mesonephric ducts regress (no testosterone). The cranial unfused portions form the **fallopian tubes** (open into the peritoneal cavity as fimbriae). The caudal portions fuse in the midline to form the **uterovaginal primordium** → **uterus, cervix, and upper 1/3 of the vagina**. The fused ducts form the broad ligament. The lower 2/3 of the vagina comes from the **urogenital sinus** (sinovaginal bulbs), so the vagina has a dual origin. - **Male:** SRY → SOX9 → Sertoli cells secrete **AMH (Müllerian-inhibiting substance)**, causing ipsilateral paramesonephric duct regression. Leydig cell testosterone preserves the mesonephric ducts (epididymis, vas deferens, seminal vesicles, ejaculatory duct); DHT drives external genitalia and prostate. Remnants: appendix testis and prostatic utricle. - Associated tissue: the paramesonephric and mesonephric ducts share the intermediate mesoderm origin; the urogenital ridge also gives rise to the kidneys and gonads, so Müllerian anomalies often coexist with **renal anomalies** (e.g., unilateral renal agenesis).

**Clinical correlates** - **Müllerian agenesis (Mayer-Rokitansky-Küster-Hauser, MRKH):** 46,XX, normal ovaries, normal secondary sexual characteristics, normal female external genitalia, but absent uterus and upper vagina → primary amenorrhea with a blind-ending vaginal pouch. Associated with renal and skeletal anomalies. - **Androgen insensitivity syndrome (46,XY):** Testes make AMH → no uterus/tubes; blind vaginal pouch; absent/scant pubic and axillary hair; primary amenorrhea; elevated testosterone and LH. Key differentiator from MRKH (karyotype, pubic hair, testosterone level). - **Persistent Müllerian duct syndrome:** 46,XY with AMH or AMH receptor defect; males with a uterus/fallopian tubes, often found incidentally during inguinal hernia repair or with cryptorchidism. - **Failure of fusion/resorption:** Uterus didelphys (complete nonfusion; two uteri, two cervices, sometimes double vagina), bicornuate uterus (partial fusion failure), septate uterus (failure of septal resorption; most common anomaly and associated with the highest rate of recurrent pregnancy loss; treat with hysteroscopic septum resection), unicornuate uterus (one duct fails to develop). These are associated with recurrent miscarriage, preterm labor, malpresentation, and infertility. - **Imperforate hymen / transverse vaginal septum:** Failed canalization (urogenital sinus/vaginal plate junction) → cyclic pelvic pain with primary amenorrhea, hematocolpos, bulging bluish membrane. - **DES (diethylstilbestrol) exposure in utero:** Disrupts Müllerian development → T-shaped uterus, clear cell adenocarcinoma of the vagina/cervix, vaginal adenosis, and increased risk of ectopic pregnancy and cervical incompetence. - **Gartner duct cysts:** Remnants of the mesonephric duct (not the paramesonephric duct) in the vaginal wall. Don't confuse the two.

**High-yield mnemonics/pearls** - Müllerian = "Mother" structures (female internal genitalia); Wolffian = "Warrior/male" (SEED: Seminal vesicles, Epididymis, Ejaculatory duct, Ductus deferens). - Female genital development is the default; male development requires active SRY, AMH, and testosterone/DHT. - Ovarian development and function are NOT dependent on the paramesonephric duct, so MRKH patients have normal ovarian hormones and can have genetic offspring via surrogacy/IVF. - Evaluate Müllerian anomalies with pelvic ultrasound/MRI (and hysterosalpingography); check the urinary tract for associated anomalies.